The drug KAMAN contains one active pharmaceutical ingredient (API):
Paromomycin is an aminoglycoside antibiotic derived from Streptomyces rimosus var paromomycinus, with amebicidal and antibacterial activity. Paromomycin binds specifically to the RNA oligonucleotide at the A site of bacterial 30S ribosomes, thereby causing misreading and premature termination of translation, thereby leading to inhibition of protein synthesis followed by cell death.
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
This brand name is authorized in the following countries: Italy
This drug has been assigned below unique identifiers within the countries it is being marketed: